Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion type Assertion NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_head.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion description "[The EGF A61G G/G genotype conferred increased EAC risk, with an adjusted odds ratio of 1.81 (95% confidence interval, 1.2-2.7), and was even higher in the subgroup of EAC patients with concurrent Barrett's esophagus (adjusted odds ratio, 2.18; 95% confidence interval, 1.3-3.7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_provenance.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion evidence source_evidence_literature NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_provenance.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion SIO_000772 18483390 NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_provenance.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion wasDerivedFrom befree-20140225 NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_provenance.
- NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_assertion wasGeneratedBy ECO_0000203 NP410638.RAAr9pdaUIh_TUK7pfju5w5Stt-ILili2Tps82bd5s6iw130_provenance.